Modular Medical (MODD) director awarded 83 shares after 1-for-30 reverse split

Rhea-AI Filing Summary

DeSisto Duane M reported acquisition or exercise transactions in this Form 4 filing.

Modular Medical, Inc. director Duane M. DeSisto received a grant of 83 shares of common stock on March 31, 2026 as compensation under the company’s Outside Director Compensation Plan. The grant was at no cash cost per share and brought his directly held stake to 8,544 shares.

A 1-for-30 reverse stock split of Modular Medical’s common stock, effective March 31, 2026, is reflected in the reported share amounts, meaning both the grant and total holdings are shown on a post-split basis.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider DeSisto Duane M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common stock	83	$0.00	--

Holdings After Transaction: Common stock — 8,544 shares (Direct)

Footnotes (1)

1. The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan. Share amount reflects the impact of a 1-for-30 reverse stock split of the Issuer's common stock effected on March 31, 2026.

Key Figures

Director share grant: 83 shares Grant price per share: $0.0000 per share Shares held after transaction: 8,544 shares +1 more

4 metrics

Director share grant 83 shares Common stock grant on March 31, 2026

Grant price per share $0.0000 per share Compensation award, non-cash

Shares held after transaction 8,544 shares Director Duane M. DeSisto, post-transaction holdings

Reverse stock split ratio 1-for-30 Common stock split effective March 31, 2026

Key Terms

Outside Director Compensation Plan, reverse stock split, Common stock

3 terms

Outside Director Compensation Plan financial

"The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan."

reverse stock split financial

"Share amount reflects the impact of a 1-for-30 reverse stock split of the Issuer's common stock effected on March 31, 2026."

A reverse stock split is when a company reduces the number of its shares outstanding, making each share more valuable. For example, if you own 100 shares worth $1 each, a 1-for-10 reverse split would turn your 100 shares into 10 shares worth $10 each. Companies often do this to boost their stock price and appear more stable to investors.

Common stock financial

"security_title: Common stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DeSisto Duane M

(Last) (First) (Middle)

C/O MODULAR MEDICAL, INC.

10740 THORNMINT ROAD

(Street)

SAN DIEGO CALIFORNIA 92127

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Modular Medical, Inc. [ MODD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	03/31/2026		A		83	A	(1)	8,544(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan.

2. Share amount reflects the impact of a 1-for-30 reverse stock split of the Issuer's common stock effected on March 31, 2026.

	/s/ James Sullivan, attorney-in-fact for Duane M. DeSisto	04/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Modular Medical (MODD) report for Duane DeSisto?

Modular Medical reported that director Duane M. DeSisto received a grant of 83 shares of common stock on March 31, 2026. The shares were issued as compensation under the company’s Outside Director Compensation Plan, increasing his directly held position to 8,544 shares after the transaction.

Was the Modular Medical (MODD) director share grant an open-market purchase or compensation?

The 83-share transaction for director Duane M. DeSisto was a compensation grant, not an open-market purchase. The filing states the issuer issued these shares under its Outside Director Compensation Plan, with a reported price per share of $0.0000, indicating a non-cash award.

How many Modular Medical (MODD) shares does Duane DeSisto hold after this Form 4 transaction?

After receiving the 83-share grant on March 31, 2026, director Duane M. DeSisto directly holds 8,544 shares of Modular Medical common stock. This total is shown on a post-split basis, reflecting the company’s 1-for-30 reverse stock split effective the same date.

What is the significance of the 1-for-30 reverse stock split for Modular Medical (MODD) shares?

The filing notes a 1-for-30 reverse stock split of Modular Medical’s common stock effective March 31, 2026. This means every 30 pre-split shares became one post-split share, and all reported share amounts, including the grant and holdings, are presented on this adjusted basis.

Does the March 31, 2026 MODD Form 4 show any insider share sales?

The March 31, 2026 Form 4 for Modular Medical shows only an acquisition transaction for director Duane M. DeSisto. It reports a single grant of 83 common shares as compensation, with no sales, dispositions, or derivative exercises disclosed in the provided transaction summary.